How people use cigarettes, e-cigarettes, and heated tobacco products worldwide
Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study
This project looks at how government rules and company actions affect adults' use of cigarettes, vapes, and heated tobacco across different countries.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11380258 on NIH RePORTER |
What this research studies
I would be part of a global effort that uses the same surveys and common analysis methods to compare how people in different countries start, switch between, or stop using cigarettes, e-cigarettes, and heated tobacco products. The team tracks trends in product use and examines the effects of product design, price, placement, and promotion on people's choices and beliefs. They collect and combine data from multiple countries to see how different policies and industry actions influence behavior. Adding heated tobacco products lets them study three nicotine products together to understand real-world transitions and impacts.
Who could benefit from this research
Good fit: Ideal participants are adults (typically 21 and older) who currently use or have used cigarettes, e-cigarettes, or heated tobacco, or who are at risk of starting.
Not a fit: People under 21 and those who never use nicotine products are unlikely to gain direct benefit from participating.
Why it matters
Potential benefit: If successful, the work could inform policies and programs that reduce smoking and vaping harms and help more people quit or avoid starting.
How similar studies have performed: Previous International Tobacco Control (ITC) studies have linked policies to changes in smoking and vaping behavior, and this project builds on that established approach.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Cummings, Kenneth Michael — Medical University of South Carolina
- Study coordinator: Cummings, Kenneth Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.